Gallagher Kathleen P. sold RNA
December 17, 2025 · Form 4 insider transaction
Gallagher Kathleen P. sold 8,030 shares of Atrium Therapeutics, Inc. at $71.87 per share, a transaction worth $577.1K. The trade was recorded as shares withheld for taxes and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Disposed (sell-side)
Shares
8,030
Price
$71.87
Total value
$577.1K
InsiderGallagher Kathleen P.
RoleOfficer, Director
SecurityCommon Stock
Transaction codeF: Shares withheld for taxes
Transaction dateDecember 17, 2025
Filing dateDecember 19, 2025
Shares owned after80,838
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents the number of shares withheld by the Issuer to cover tax withholding in connection with the settlement of restricted stock units on December 17, 2025.